Richard E. Lowenthal - PRESIDENT AND CEO, Director, 10%+ Owner at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director, 10%+ Owner
Stock Symbol
SPRY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Richard E. Lowenthal - trading volume in the past year for ARS Pharmaceuticals, Inc.

Holdings reported by Richard E. Lowenthal for ARS Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.33M $50.5M $11.67 Dec 17, 2024 Direct
Common Stock 3.43M $40.1M $11.67 Dec 17, 2024 By Spouse
Common Stock 1.3M $15.1M $11.67 Dec 17, 2024 By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
Common Stock 1.25M $14.5M $11.67 Dec 17, 2024 By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020
Common Stock 1.1M $12.8M $11.67 Dec 17, 2024 By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Stock Option (right to buy) 1.09M Dec 6, 2024 Direct Common Stock
Stock Option (right to buy) 338K Dec 6, 2024 By Spouse Common Stock

Transactions reported by Richard E. Lowenthal for ARS Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.